CBI

Leading life science success

CBI is Israel’s largest life sciences holding company

about cbi

Clal Biotechnology Industries (TASE: CBI) is Israel’s leading life sciences investment company. CBI supports life sciences by identifying and powering science backed ventures and proactively guiding them to transform the healthcare industry.

portfolio

The CBI portfolio is comprised of biotechnology and medical device companies developing breakthrough solutions for serious unmet medical needs, while offering substantial value and investment potential.

+

MediWound

MediWound (Nasdaq: MDWD) is a specialty biotechnology company focused on the fields of severe burn and chronic wound management.
+

Gamida Cell

Gamida Cell is a cell and immune therapy visionary. Lead product, NiCord® is currently in phase III clinical trial in hematological malignancies.
+

Anchiano (formerly Biocancell)

Anchiano Therapeutics (TASE: ANCN) is a clinical stage biopharmaceutical company dedicated to developing new therapies for non-muscle-invasive bladder cancer.
+

Elicio

Elicio develops platform technologies to deliver agents directly to the antigen-presenting cells of the lymph nodes with many potential applications in cancer
+

Neon Therapeutics

Neon Therapeutics (Nasdaq: NTGN) is a clinical stage, immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer.
+

Cadent Therapeutics

Cadent Therapeutics is developing novel drugs for neurological and psychiatric disorders.
+

Exithera

eXIthera Pharmaceuticals is a clinical stage biotech company focused on discovering and developing Factor XIa inhibitors for the prevention of stroke and thrombosis.
+

Biokine

Biokine Therapeutics is company focused on developing novel therapeutics to treat cancer. It's lead product, BL-8040, is licensed to BiolineRx and is in phase III clinical development.

See complete portfolio

Press Releases

2020

30

Mar

MediWound: Update Related to the COVID-19 Pandemic
18

Mar

Sight Diagnostics: Blood Analyser OLO Deployed in Israeli Hospital to Help Support Coronavirus Quarantine Measures
17

Mar

Neon: Collaborations between BioNTech and Fosun Pharma and BioNTech and Pfizer to develop potential COVID-19 vaccine
11

Mar

Cadent Therapeutics: CAD-9303 for Schizophrenia gets IND Application Clearance, Initiating Dosing of Subjects
03

Mar

Elicio Therapeutics: $8.5 Million Financing Round
03

Mar

MediWound: BARDA Upsizes its Contract with MediWound with $5.5 Million for Emergency Readiness for NexoBrid Deployment

Read all Press Releases